Sfoglia per Autore
HEMOFILTRATION: PREDILUTION VERSUS POSTDILUTION
1992-01-01 David, Salvatore; Cambi, Vincenzo
ROLE OF PLATELET ACTIVATING FACTOR IN HEMODIALYSIS.
1993-01-01 Tetta, C; David, Salvatore; Biancone, L; Canino, F; Cambi, Vincenzo; Camussi, G.
ADEQUACY OF TREATMENT OF UREMIA IN THE NINETIES
1993-01-01 David, Salvatore; Cambi, Vincenzo
ADHERENCE OF HUMAN MONOCYTES TO HAEMODIALYSIS MEMBRANES
1993-01-01 David, Salvatore; Tetta, C; Camussi, G; Canino, F; Almici, C; Rizzoli, V; Cambi, Vincenzo
PRODUCTION OF PLATELET ACTIVATING FACTOR BY HUMAN NEUTROPHILS AFTER BACKFILTRATION OF ENDOTOXIN CONTAMINATED DIALYSATE.
1993-01-01 David, Salvatore; Tetta, C; Canino, F; Gervasio, R; Cambi, Vincenzo
ALTERNATIVE PATHWAY ACTIVATION OF COMPLEMENT BY CULTURED HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS
1994-01-01 Biancone, L; David, Salvatore; Della Pietra, V; Montrucchio, G; Cambi, Vincenzo; Camussi, G.
THE COST/BENEFIT RATIO OF RENAL REPLACEMENT THERAPY
1994-01-01 Cambi, Vincenzo; David, Salvatore
BASIC THERAPEUTIC REQUIREMENTS IN THE TREATMENT OF SEPSIS IN ACUTE RENAL FAILURE
1994-01-01 Cambi, Vincenzo; David, Salvatore
THE HEMATOPOIETIC SYSTEM IN RENAL FAILURE
1994-01-01 Cambi, Vincenzo; David, Salvatore
CORRECTION OF UREMIC ACIDOSIS BY HEMODIALYSIS
1994-01-01 David, Salvatore; Caserta, C; Cambi, Vincenzo
PREDILUTION HEMOFILTRATION. CLINICAL EXPERIENCE AND REMOVAL OF SMALL MOLECULAR WEIGHT SOLUTES
1995-01-01 David, Salvatore; M., Bostrom; Cambi, Vincenzo
THE ROLE OF PLATELET-ACTIVATING FACTOR IN THE BIOCOMPATIBILITY OF HEMODIALYSIS MEMBRANES
1996-01-01 C., Tetta; N., Haeffner Cavaillon; C., Navino; David, Salvatore; C., Franceschi; F., Mariano; G., Camussi
ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION INDUCES PROINFLAMMATORY ACTIVITY IN HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS.
1997-01-01 David, Salvatore; Biancone, L; Caserta, C; Bussolati, B; Cambi, Vincenzo; Camussi, G.
IN VITRO AND IN VIVO BIOCOMPATIBILITY OF SUBSTITUTED CELLULOSE AND SYNTHETIC MEMBRANES
1997-01-01 Mandolfo, S; Tetta, C; David, Salvatore; Gervasio, R; Ognibene, D; Wratten, Ml; Tessore, E; Imbasciati, E.
Identification of operational clues to dry weight prescription in hemodialysis using bioimpedance vector analysis
1998-01-01 A., Piccoli; S., Agliata; S., Alloatti; P., Bajardi; G., Bazzato; L., Bibiano; R., Boero; C., Bonesso; E., Bordoni; M., Briganti; C., Bronzieri; G., Bufano; A., Caberlotto; S., Cantafio; F., Casino; P., Ciccarelli; A., Confessore; E., Coppola; David, Salvatore; M., Di Dio; B., Di Iorio; N., Di Paolo; M., Farina; E., Favaro; F., Fiorini; G., Giacchetta; J., Nachtigal; W., Passler; L., Pedrini; A., Pellerano; G., Pertosa; A., Piccoli; L., Pillon; M., Piva; G., Quintaliani; G., Raccosta; B., Rossi; G., Splendiani; L., Stanic; E., Talassi; T., Teodori; G., Tripepi; T., Zattera
BEHAVIOUR OF B2-MICROGLOBULIN REMOVAL WITH DIFFERENT DIALYSIS SCHEDULES
1998-01-01 David, Salvatore; D., Bottalico; D., Tagliavini; S., Mandolfo; R., Scanziani; Cambi, Vincenzo
High-efficiency dialysis with PMMA dialyzers: treatment dose delivery and long-term results
1999-01-01 David, Salvatore; Cambi, Vincenzo
Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change
1999-01-01 Bussolati, B.; Mariano, F.; Biancone, L.; Foa, R.; David, Salvatore; Cambi, Vincenzo; Camussi, G.
An overview of hemodialysis and oxidant stress
1999-01-01 C., Tetta; S., Biasioli; R., Schiavon; P., Inguaggiato; David, Salvatore; V., Panichi; Wratten, M. L.
Tolerance to ultrafiltration in hemodialysis
2000-01-01 David, Salvatore; P., Manna; D., Gerra; F., Cardarelli; F., ABU SHALHOUB; V., Cambi
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
HEMOFILTRATION: PREDILUTION VERSUS POSTDILUTION | 1-gen-1992 | David, Salvatore; Cambi, Vincenzo | |
ROLE OF PLATELET ACTIVATING FACTOR IN HEMODIALYSIS. | 1-gen-1993 | Tetta, C; David, Salvatore; Biancone, L; Canino, F; Cambi, Vincenzo; Camussi, G. | |
ADEQUACY OF TREATMENT OF UREMIA IN THE NINETIES | 1-gen-1993 | David, Salvatore; Cambi, Vincenzo | |
ADHERENCE OF HUMAN MONOCYTES TO HAEMODIALYSIS MEMBRANES | 1-gen-1993 | David, Salvatore; Tetta, C; Camussi, G; Canino, F; Almici, C; Rizzoli, V; Cambi, Vincenzo | |
PRODUCTION OF PLATELET ACTIVATING FACTOR BY HUMAN NEUTROPHILS AFTER BACKFILTRATION OF ENDOTOXIN CONTAMINATED DIALYSATE. | 1-gen-1993 | David, Salvatore; Tetta, C; Canino, F; Gervasio, R; Cambi, Vincenzo | |
ALTERNATIVE PATHWAY ACTIVATION OF COMPLEMENT BY CULTURED HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS | 1-gen-1994 | Biancone, L; David, Salvatore; Della Pietra, V; Montrucchio, G; Cambi, Vincenzo; Camussi, G. | |
THE COST/BENEFIT RATIO OF RENAL REPLACEMENT THERAPY | 1-gen-1994 | Cambi, Vincenzo; David, Salvatore | |
BASIC THERAPEUTIC REQUIREMENTS IN THE TREATMENT OF SEPSIS IN ACUTE RENAL FAILURE | 1-gen-1994 | Cambi, Vincenzo; David, Salvatore | |
THE HEMATOPOIETIC SYSTEM IN RENAL FAILURE | 1-gen-1994 | Cambi, Vincenzo; David, Salvatore | |
CORRECTION OF UREMIC ACIDOSIS BY HEMODIALYSIS | 1-gen-1994 | David, Salvatore; Caserta, C; Cambi, Vincenzo | |
PREDILUTION HEMOFILTRATION. CLINICAL EXPERIENCE AND REMOVAL OF SMALL MOLECULAR WEIGHT SOLUTES | 1-gen-1995 | David, Salvatore; M., Bostrom; Cambi, Vincenzo | |
THE ROLE OF PLATELET-ACTIVATING FACTOR IN THE BIOCOMPATIBILITY OF HEMODIALYSIS MEMBRANES | 1-gen-1996 | C., Tetta; N., Haeffner Cavaillon; C., Navino; David, Salvatore; C., Franceschi; F., Mariano; G., Camussi | |
ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION INDUCES PROINFLAMMATORY ACTIVITY IN HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS. | 1-gen-1997 | David, Salvatore; Biancone, L; Caserta, C; Bussolati, B; Cambi, Vincenzo; Camussi, G. | |
IN VITRO AND IN VIVO BIOCOMPATIBILITY OF SUBSTITUTED CELLULOSE AND SYNTHETIC MEMBRANES | 1-gen-1997 | Mandolfo, S; Tetta, C; David, Salvatore; Gervasio, R; Ognibene, D; Wratten, Ml; Tessore, E; Imbasciati, E. | |
Identification of operational clues to dry weight prescription in hemodialysis using bioimpedance vector analysis | 1-gen-1998 | A., Piccoli; S., Agliata; S., Alloatti; P., Bajardi; G., Bazzato; L., Bibiano; R., Boero; C., Bonesso; E., Bordoni; M., Briganti; C., Bronzieri; G., Bufano; A., Caberlotto; S., Cantafio; F., Casino; P., Ciccarelli; A., Confessore; E., Coppola; David, Salvatore; M., Di Dio; B., Di Iorio; N., Di Paolo; M., Farina; E., Favaro; F., Fiorini; G., Giacchetta; J., Nachtigal; W., Passler; L., Pedrini; A., Pellerano; G., Pertosa; A., Piccoli; L., Pillon; M., Piva; G., Quintaliani; G., Raccosta; B., Rossi; G., Splendiani; L., Stanic; E., Talassi; T., Teodori; G., Tripepi; T., Zattera | |
BEHAVIOUR OF B2-MICROGLOBULIN REMOVAL WITH DIFFERENT DIALYSIS SCHEDULES | 1-gen-1998 | David, Salvatore; D., Bottalico; D., Tagliavini; S., Mandolfo; R., Scanziani; Cambi, Vincenzo | |
High-efficiency dialysis with PMMA dialyzers: treatment dose delivery and long-term results | 1-gen-1999 | David, Salvatore; Cambi, Vincenzo | |
Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change | 1-gen-1999 | Bussolati, B.; Mariano, F.; Biancone, L.; Foa, R.; David, Salvatore; Cambi, Vincenzo; Camussi, G. | |
An overview of hemodialysis and oxidant stress | 1-gen-1999 | C., Tetta; S., Biasioli; R., Schiavon; P., Inguaggiato; David, Salvatore; V., Panichi; Wratten, M. L. | |
Tolerance to ultrafiltration in hemodialysis | 1-gen-2000 | David, Salvatore; P., Manna; D., Gerra; F., Cardarelli; F., ABU SHALHOUB; V., Cambi |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile